# Metadherin mRNA Expression in Bladder Cancer

> **NCT04286672** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 70 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Metadherin

## Key facts

- **NCT ID:** NCT04286672
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12
- **Primary completion:** 2021-01
- **Final completion:** 2022-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2020-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04286672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04286672, "Metadherin mRNA Expression in Bladder Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04286672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*